(Q45098418)

9 December 2017

title

Preparation and characterization of nickel nanoparticles for binding to his-tag proteins and antigens (English)

1 reference

9 December 2017

0 references

0 references

Jigna D Patel

1

1 reference

9 December 2017

Ronan O'Carra

2

1 reference

9 December 2017

Julia Jones

3

1 reference

9 December 2017

Jerold G Woodward

4

1 reference

9 December 2017

Russell J Mumper

5

1 reference

9 December 2017

publication date

19 December 2006

1 reference

9 December 2017

published in

Pharmaceutical Research

1 reference

9 December 2017

volume

24

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

343-352

1 reference

Adjuvants for human vaccines--current status, problems and future prospects

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Recent advances in vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Microparticles as vaccine adjuvants and delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Oligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Recent developments in adjuvants for vaccines against infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2 SF162) to anionic PLG microparticles retains the structural integrity of the protein, whereas encapsulation in PLG microparticles does not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Charged polylactide co-glycolide microparticles as antigen delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Coating of cationized protein on engineered nanoparticles results in enhanced immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

The development and application of protein-liposome conjugation techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Metal chelate affinity chromatography, a new approach to protein fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Development and characterization of Ni-NTA-bearing microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Structure and function of a membrane-bound murine MHC class I molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

HIV-1 gag proteins: diverse functions in the virus life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Gadolinium-loaded nanoparticles engineered from microemulsion templates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Genetic immunization using nanoparticles engineered from microemulsion precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Influence of cadmium, nickel, and chromium on primary immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9154-7

New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues

21 January 2018

1 reference

12 December 2020

T cell genetic background determines maintenance of IL-12 signaling: effects on BALB/c and B10.D2 T helper cell type 1 phenotype development

1 reference

12 December 2020

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

1 reference

12 December 2020

One-step purification of recombinant proteins with the 6xHis tag and Ni-NTA resin.

1 reference

12 December 2020

Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen

1 reference

12 December 2020

Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.

1 reference

12 December 2020

Immunologic effects of nickel: I. Suppression of cellular and humoral immunity

1 reference

12 December 2020

HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant

1 reference

12 December 2020

A new hydrophobic anchor for the attachment of proteins to liposomal membranes

1 reference

12 December 2020

Affinity purification of histidine-tagged proteins

1 reference

12 December 2020

Attaching histidine-tagged peptides and proteins to lipid-based carriers through use of metal-ion-chelating lipids.

1 reference

12 December 2020

Microparticles and polymers for the mucosal delivery of vaccines

1 reference

12 December 2020

4th meeting on Novel Adjuvants Currently in/close to Human Clinical Testing World Health Organization -- organisation Mondiale de la Santé Fondation Mérieux, Annecy, France, 23-25, June 2003

1 reference

12 December 2020

10.1007/S11095-006-9154-7

Identifiers

DOI

1 reference

9 December 2017

1 reference